• Embed Doc
  • Readcast
  • Collections
  • CommentGo Back
Download
 
DOI: 10.1126/science.1151526, 1917 (2007);
318
Science 
 
et al.
Junying Yu,
Human Somatic CellsInduced Pluripotent Stem Cell Lines Derived from
 
www.sciencemag.org (this information is current as of January 30, 2008 ): The following resources related to this article are available online at 
 http://www.sciencemag.org/cgi/content/full/318/5858/1917version of this article at:including high-resolution figures, can be found in the online
Updated information and services,
found at:can be
related to this article
subject collections
this articlepermission to reproduce
of this article or about obtaining
reprints
Information about obtainingregistered trademark of AAAS.is a
Science 
2007 by the American Association for the Advancement of Science; all rights reserved. The titleCopyrightAmerican Association for the Advancement of Science, 1200 New York Avenue NW, Washington, DC 20005.(print ISSN 0036-8075; online ISSN 1095-9203) is published weekly, except the last week in December, by the
Science 
   o  n   J  a  n  u  a  r  y   3   0 ,   2   0   0   8  w  w  w .  s  c   i  e  n  c  e  m  a  g .  o  r  g   D  o  w  n   l  o  a   d  e   d   f  r  o  m 
 
Induced Pluripotent Stem Cell LinesDerived from Human Somatic Cells
Junying Yu,
1,2
*
Maxim A. Vodyanik,
2
Kim Smuga-Otto,
1,2
Jessica Antosiewicz-Bourget,
1,2
Jennifer L. Frane,
1
Shulan Tian,
3
Jeff Nie,
3
Gudrun A. Jonsdottir,
3
Victor Ruotti,
3
Ron Stewart,
3
Igor I. Slukvin,
2,4
James A. Thomson
1,2,5
*Somatic cell nuclear transfer allows trans-acting factors present in the mammalian oocyte toreprogram somatic cell nuclei to an undifferentiated state. We show that four factors (
OCT4
,
SOX2
,
NANOG 
, and
LIN28
) are sufficient to reprogram human somatic cells to pluripotent stem cells thatexhibit the essential characteristics of embryonic stem (ES) cells. These induced pluripotent humanstem cells have normal karyotypes, express telomerase activity, express cell surface markers andgenes that characterize human ES cells, and maintain the developmental potential to differentiateinto advanced derivatives of all three primary germ layers. Such induced pluripotent human celllines should be useful in the production of new disease models and in drug development, as well asfor applications in transplantation medicine, once technical limitations (for example, mutationthrough viral integration) are eliminated.
M
ammalian embryogenesis elaboratesdistinctdevelopmentalstagesinastrict temporal order. Nonetheless, becausedevelopment is dictated by epigenetic rather thangenetic events, differentiation is, in principle, re-versible. The cloning of Dolly demonstrated that nuclei from mammalian differentiated cells can be reprogrammed to an undifferentiated state bytrans-acting factors present in the oocyte (
1
), andthis discovery led to a search for factors that couldmediate similar reprogramming without somaticcell nuclear transfer. Recently, four transcriptionfactors(
Oct4
,
Sox2
,
c-myc
,and
 Klf4
)wereshowntobe sufficienttoreprogrammouse fibroblaststoundifferentiated, pluripotent stem cells [termedinduced pluripotent stem (iPS) cells] (
2
 – 
5
). Re- programming human cells by defined factorswould allow the generation of patient-specific pluripotent cell lines without somatic cell nuclear transfer, but the observation that the expressionof c-Myc causes death and differentiation of hu-man ES cells suggests that combinations of fac-tors lacking this gene are required to reprogramhuman cells (
). We demonstrate that 
OCT4
,
SOX2
,
NANOG 
, and
LIN28
are sufficient to re- program human somatic cells.Human ES cells can reprogram myeloid pre-cursors through cell fusion (
). To identify can-didate reprogramming factors, we compiled a list of genes with enriched expression in human EScells relative to that of myeloid precursors and prioritizedthelistbasedonknowninvolvementinthe establishment or maintenance of pluripotency(table S1). We then cloned these genes into lentiviral vector (fig. S1) to screen for combi-nations of genes that could reprogram the differ-entiated derivatives of an
OCT4
knock-in humanES cell line generated through homologous re-combination(
8
).Inthiscellline,theexpressionof neomycin phosphotransferase, which makes cellsresistant to geneticin, is driven by an endogenous
OCT4
 promoter,agenethatishighlyexpressedin pluripotent cells but not in differentiated cells.Thus, reprogramming events reactivating the
OCT4
promoter can be recovered by geneticinselection. The first combination of 14 genes that weselected(tableS2)directedthereprogrammingofadherentcells,whichwerederivedfromhumanES cell
 – 
derivedCD45
+
hematopoietic cells (
,
9
),to geneticin-resistant (OCT4
+
) colonies with anES cell morphology (fig. S2A) (
10
). Thesegeneticin-resistant colonies expressed typicalhuman ES cell
 – 
specific cell surface markers(fig. S2B) and formed teratomas when injectedinto immunocompromised severe combined im-munodeficient 
 – 
 beige mice (fig. S2C).By testing subsets of the 14 initial genes, weidentified a core set of 4 genes,
OCT4
,
SOX2
,
 NANOG 
, and
LIN28
, that were capable of re- programming human ES cell
 – 
derived somaticcells with a mesenchymal phenotype (Fig. 1Aand fig. S3). Removal of either 
OCT4
or 
SOX2
from the reprogramming mixture eliminated theappearance of geneticin-resistant (OCT4
+
) re- programmed mesenchymal clones (Fig. 1A).
 NANOG 
showed a beneficial effect in clonerecovery from human ES cell
 – 
derived mesen-chymal cells but was not required for the initialappearance of such clones (Fig. 1A). Theseresults are consistent with cell fusion
 – 
mediatedreprogramming experiments, where overexpres-sion of Nanog in mouse ES cells resulted in over a 200-fold increase in reprogramming efficiency(
11
). The expression of NANOG also improvesthecloningefficiencyofhumanEScells(
12
)andthus could increase the survival rate of earlyreprogrammed cells.
LIN28
had a consistent but moremodesteffectonreprogrammedmesenchy-mal cell clone recovery (Fig. 1A).We next tested whethe
OCT4
,
SOX2
,
 NANOG 
, and
LIN28
are sufficient to reprogram
1
Genome Center of Wisconsin, Madison, WI 53706
1580,USA.
2
Wisconsin National Primate Research Center,University of Wisconsin-Madison, Madison, WI 53715
1299, USA.
3
WiCell Research Institute, Madison, WI53707
7365, USA.
4
Department of Pathology andLaboratory Medicine, University of Wisconsin-Madison,Madison, WI 53706, USA.
5
Department of Anatomy,University of Wisconsin-Madison, Madison, WI 53706
1509, USA.*To whom correspondence should be addressed. E-mail:jyu@primate.wisc.edu (J.Y.); thomson@primate.wisc.edu(J.A.T.)
Fig. 1.
Optimizationofhuman reprogramminggene combinations withmesenchymal cells de-rivedfromhuman
OCT4
knock-inH1EScells.(
A
)Effect of removal of in-dividualgenesfromtheM4 (
OCT4
,
NANOG 
,
 SOX2
, and
LIN28
) re-programming mixture.HumaniPScolonieswerecountedonday15afterlentiviral transduction.Control indicates no transduction or indicates that cells were transduced with
NANOG 
only. In three independent experiments with different preparationsof mesenchymal cells, individual removal of either
OCT4
or
SOX2
from re-programming combinations eliminated the appearance of reprogrammedclones, whereas the individual removal of either
NANOG 
or
LIN28
reducedthenumber of reprogrammed clones but did not eliminate such clones entirely.The data presented are from one representative experiment. (
B
) Bright-field images of IMR90 fibroblasts (p18) and iPS(IMR90)-3 (p18+p18),where the first p18 refers to the passage number of IMR90 fibroblasts, andthe second p18 means that the reprogrammed clones underwent 18passages on irradiated mouse embryonic fibroblasts (MEFs). Scale bars,50
m
m.
050100150200250300350ControlM4(-)OCT4M4(-)NANOGM4(-)SOX2M4(-)LIN28M4
Gene combinations
TotalLarge colonies with minimal differentiation
   #  o   f   i   P   S   c  o   l  o  n   i  e  s
AB
iPS(IMR90)-3IMR90
www.sciencemag.org
SCIENCE
VOL 318 21 DECEMBER 2007
1917
REPORTS
   o  n   J  a  n  u  a  r  y   3   0 ,   2   0   0   8  w  w  w .  s  c   i  e  n  c  e  m  a  g .  o  r  g   D  o  w  n   l  o  a   d  e   d   f  r  o  m 
 
 primary, genetically unmodified, diploid humanfibroblasts. We initially chose IMR90 fetal fibro- blasts, because these diploid human cells are beingextensivelycharacterized bytheENCODEConsortium (
13
), are readily available throughthe American Type Culture Collection [(ATCC),catalog number CCL-186], and have publishedDNA fingerprints that allow confirmation of theoriginofreprogrammedclones.IMR90cellsalso proliferate robustly for more than 20 passages beforeundergoingsenescencebutgrowslowlyinhuman ES cell culture conditions, a differencethat provides a proliferative advantage to repro-grammed clones and aids in their selection bymorphological criteria (e.g., compact colonies,high nucleus-to-cytoplasm ratios, and prominent nucleoli) alone (
14
,
15
). IMR90 cells weretransduced with a combination of 
OCT4
,
SOX2
,
 NANOG 
, and
LIN28
. Colonies with a human EScell morphology (iPS colonies) first becamevisible 12 days after transduction. On day 20, a 
A BC D
SSEA-3SSEA-4Tra-1-60Tra-1-81iPS(IMR90)-3IMR90iPS(foreskin)-3Foreskin
00.050.10.150.20.250.30.350.4
iPS(IMR90)iPS(foreskin)OCT4NANOGSOX2LIN28OCT4endo
   H  1    E  S  C
12344123
   H  1    E  S  C
iPS(IMR90)iPS(foreskin)
  a  m  o   l  e  s   /
     µ
  g  p  r  o   t  e   i  n
12345678910111213141516171819202122XY
   12341234   I   M   R   9   0   F  o  r  e  s   k   i  n   H   1   E   S   C
Fig. 2.
ReprogrammingofIMR90fi-broblasts.(
A
)G-bandingchromosomeanalysisofiPS(IMR90)-3(p18+p23).(
B
) Telomerase activity is shownfor the following: iPS(IMR90)-1 toiPS(IMR90)-4, p18+p22(20) [wherep18 refers to the passage number ofIMR90 fibroblasts and where p22(20)means that the reprogrammed clonesunderwent 22 passages, with 2 onMEFand20onmatrigelinhumanEScellculturemediumconditionedwithMEF(CM)];IMR90,p18;iPS(foreskin)-1toiPS(foreskin)-4,p10+p9(5);Foreskin,p10;andH1 ESC (human H1 ES cells), p63(13) [wherethere was a total of 63 passages, with 50 onMEF and 13 on matrigel in CM]. The data arepresented as mean ± SD from three telomer-aseactivityassays.(
C
)Flowcytometryexpressionanalyses of human ES cell-specific cell surfacemarkers. Gray line, isotype control; black line,antigen staining. iPS(IMR90)-3, p18+p5(3);IMR90, p18; iPS(foreskin)-3, p10+p8(4); and Foreskin, p10. (
D
) Provirus integration in iPS cells.Transgene-specific primers were used to amplify
OCT4
,
NANOG 
,
SOX2
, and
LIN28
provirus, whereasprimers specific for the endogenous
OCT4
gene (OCT4endo) were used as a positive control.
Fig. 3.
Global gene expressionanalyses of iPS cells. (
A
) Pearsoncorrelation analyses of global geneexpression (47,759 transcripts) iniPS(IMR90) clones [p18+p6(4)],IMR90fibroblasts(p19),iPS(foreskin)clones [p10+p7(3)], foreskin fibro-blasts (p10), and five human ES celllines:H1[p42(12)],H7[p73(3)],H9[p50(5)], H13 [p43(5)], and H14[p61(5)] ES cells (GEO accessionnumber GSE9164). 1-PCC, Pearsoncorrelation coefficient. (
B
) Quan-titative reverse transcription
– 
PCRanalyses of OCT4 and NANOG ex-pression in iPS(IMR90) [p18+p6(4)]andiPS(foreskin)clones [p10+p7(3)].IMR90, p19; foreskin fibroblasts,p10; and H1 ESC, p42(12).
Endog-enous
indicates that primers wereincluded in the 3
untranslated re-gion measure expression of the en-dogenousgeneonly,whereas
total
indicates that primers in coding re-gions measure expression of boththeendogenousgeneandthetrans-gene if present. The data are pre-sented as mean ± SD from threetelomerase activity assays.
AB
    I   M   R   9   0   E   S   C  -   H   1   3   E   S   C  -   H   1   4   E   S   C  -   H   7   i   P   S   (   I   M   R   9   0   )  -   1   i   P   S   (   I   M   R   9   0   )  -   3   i   P   S   (   I   M   R   9   0   )  -   2   E   S   C  -   H   9   i   P   S   (   I   M   R   9   0   )  -   4   E   S   C  -   H   1
0.00.30.10.20.4
   1  -   P   C   C   F  o  r  e  s   k   i  n   i   P   S   (   f  o  r  e  s   k   i  n   )  -   1   i   P   S   (   f  o  r  e  s   k   i  n   )  -   4   i   P   S   (   f  o  r  e  s   k   i  n   )  -   3   i   P   S   (   f  o  r  e  s   k   i  n   )  -   2
OCT4
00.511.522.533.5
iPS(IMR90)iPS(foreskin)
TotalEndogenous
NANOG
00.511.522.53
iPS(IMR90)iPS(foreskin)
TotalEndogenous
   1234   I   M   R   9   0   1234   F  o  r  e  s   k   i  n   H   1   E   S   C1234   I   M   R   9   0   F  o  r  e  s   k   i  n   H   1   E   S   C   1234
   R  e   l  a   t   i  v  e  e  x  p  r  e  s  s   i  o  n   R  e   l  a   t   i  v  e  e  x  p  r  e  s  s   i  o  n
21 DECEMBER 2007 VOL 318
SCIENCE
www.sciencemag.org
1918
REPORTS
   o  n   J  a  n  u  a  r  y   3   0 ,   2   0   0   8  w  w  w .  s  c   i  e  n  c  e  m  a  g .  o  r  g   D  o  w  n   l  o  a   d  e   d   f  r  o  m 
of 00

Leave a Comment

You must be to leave a comment.
Submit
Characters: ...
You must be to leave a comment.
Submit
Characters: ...